LUPIN — Lupin Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Lupin, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	151,630	164,055	166,417	200,108	227,079
Cost of Revenue
Gross Profit	92,578	89,194	89,387	123,756	147,964
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	134,721	177,995	157,600	174,029	185,761
Operating Profit	16,908	-13,940	8,817	26,079	41,318
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	16,765	-13,722	7,165	24,223	40,150
Provision for Income Taxes
Net Income After Taxes	12,279	-15,094	4,477	19,356	33,063
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	12,165	-15,280	4,301	19,145	32,816
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12,165	-15,280	4,301	19,145	32,816
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	26.7	5.26	9.66	45.4	73.2
Dividends per Share